FMC Q3 Earnings Call Highlights
FMC reported Q3 revenue of $1.06B, including $639M from commercial actions, and adjusted EBITDA of -$559M. Q4 outlook was lowered, with revenue expected at $1.04B-$1.14B and adjusted EBITDA at $210M-$230M. FMC cited market challenges and pricing headwinds. The company expects full-year free cash flow to be -$350M to -$150M, including restructuring spending. FMC also announced preliminary 2027 and 2028 adjusted EBITDA targets of $650M-$730M and $760M-$840M, respectively.
How this was made
The 30-second read
Why it matters
The earnings miss and lowered guidance are likely to trigger a sell‑off in FMC shares and may influence peer valuations.
Market read
FMC's earnings and guidance revision are material for traders with exposure to agriscience equities.
What to watch
New product launches and Brazil direct‑to‑grower sales could offset short‑term weakness.
Background
FMC is a leading agricultural sciences company reporting its Q3 results and revising its Q4 outlook.
Ticker impact
Q3 earnings released with revenue, EBITDA, EPS numbers and lowered Q4 guidance.
likely downside as market prices in lower earnings and guidance
Adjusted EBITDA and EPS were negative; revenue guidance cut and higher restructuring spend signal weaker performance.
Market effects
Agricultural chemicals sector may see broader pressure from FMC's guidance downgrade.
Potential impact on North American and European ag‑input markets.
Limited to investors with exposure to FMC and related agriscience stocks.
Counterpoint
If FMC's restructuring and pricing actions succeed, upside could materialize later in the year.
Key entities
- CompanyFMC Corporation
Agricultural sciences firm reporting Q3 earnings.
- InvestorTessenderlo Group
Increased its stake to ~20% following a $403 million equity investment.
